niacin/eicosapentaenoic acid (CAT-2054)
/ BioCryst Pharmaceuticals
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 18, 2016
A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia
(clinicaltrials.gov)
- P2; N=153; Completed; Sponsor: Catabasis Pharmaceuticals; Active, not recruiting ➔ Completed
Trial completion
1 to 1
Of
1
Go to page
1